Xin Liu1, Xin Ma2, Qiming Liu2, Qingbo Huang2, Xintao Li3, Baojun Wang2, Hongzhao Li4, Xu Zhang5. 1. Department of Urology, Medical College of People's Liberation Army, Chinese People's Liberation Army General Hospital, Beijing, China; Department 2 of General Surgery, Medical College of People's Liberation Army, Chinese People's Liberation Army General Hospital, Beijing, China. 2. Department of Urology, Medical College of People's Liberation Army, Chinese People's Liberation Army General Hospital, Beijing, China. 3. Department of Urology, Medical College of People's Liberation Army, Chinese People's Liberation Army General Hospital, Beijing, China; Department of Urology, Chinese People's Liberation Army Air Force General Hospital, Beijing, China. 4. Department of Urology, Medical College of People's Liberation Army, Chinese People's Liberation Army General Hospital, Beijing, China. Electronic address: urolancet@126.com. 5. Department of Urology, Medical College of People's Liberation Army, Chinese People's Liberation Army General Hospital, Beijing, China. Electronic address: xzhang@foxmail.com.
Abstract
OBJECTIVES: To introduce a 'kidney priority' strategy in treating large renal angiomyolipoma (RAML) with retroperitoneal laparoscopic nephron sparing surgery (RLNSS). PATIENTS AND METHODS: From 2010 to 2017, 41 patients with large RAML underwent RLNSS. Distinguished from the standard practice, the kidney was preferentially mobilized and separated from the RAML. Subsequently, it was reconstructed. Finally, the RAML was resected from the perinephric fat. The perioperative variables, surgical technique and complications were reviewed. Patients were followed up with ultrasonography and computed tomography. RESULTS: RLNSS was successfully performed in 35 patients with four conversions to open surgery and two conversions to nephrectomy, respectively. Eight patients required an intraoperative blood transfusion. Seven patients experienced postoperative complications, including one wound infection, one urinary tract infection, one pneumonia, one urinary fistula and three hemorrhage. The median operation time was 167min (range, 95-285min), the median warm ischemia time was 21 min (range, 0-40 min), and the median estimated blood loss was 200 ml (range, 30-2500 ml). The median postoperative stay was 6.5 days (range, 3-11 days). Angiomyolipoma was confirmed pathologically in all patients. Median serum creatine increased after surgery, from 0.7 mg/dl (range, 0.4-1.1 mg/dl) preoperatively to 0.8 mg/dL (range, 0.5-1.4 mg/dl) postoperatively (P = 0.016). No patient required dialysis, and no recurrence was observed after a median follow-up of 35 months (range, 3-85 months). CONCLUSIONS: RLNSS is a safe, feasible, effective and minimally invasive procedure to manage large RAML in selected patients.
OBJECTIVES: To introduce a 'kidney priority' strategy in treating large renal angiomyolipoma (RAML) with retroperitoneal laparoscopic nephron sparing surgery (RLNSS). PATIENTS AND METHODS: From 2010 to 2017, 41 patients with large RAML underwent RLNSS. Distinguished from the standard practice, the kidney was preferentially mobilized and separated from the RAML. Subsequently, it was reconstructed. Finally, the RAML was resected from the perinephric fat. The perioperative variables, surgical technique and complications were reviewed. Patients were followed up with ultrasonography and computed tomography. RESULTS: RLNSS was successfully performed in 35 patients with four conversions to open surgery and two conversions to nephrectomy, respectively. Eight patients required an intraoperative blood transfusion. Seven patients experienced postoperative complications, including one wound infection, one urinary tract infection, one pneumonia, one urinary fistula and three hemorrhage. The median operation time was 167min (range, 95-285min), the median warm ischemia time was 21 min (range, 0-40 min), and the median estimated blood loss was 200 ml (range, 30-2500 ml). The median postoperative stay was 6.5 days (range, 3-11 days). Angiomyolipoma was confirmed pathologically in all patients. Median serum creatine increased after surgery, from 0.7 mg/dl (range, 0.4-1.1 mg/dl) preoperatively to 0.8 mg/dL (range, 0.5-1.4 mg/dl) postoperatively (P = 0.016). No patient required dialysis, and no recurrence was observed after a median follow-up of 35 months (range, 3-85 months). CONCLUSIONS: RLNSS is a safe, feasible, effective and minimally invasive procedure to manage large RAML in selected patients.
Authors: Yao Song; Songqiang Pang; Jinqiang Yang; Sen Li; Yaqiang He; Gongtang Luo Journal: Evid Based Complement Alternat Med Date: 2021-10-16 Impact factor: 2.629